Every cell - including cancer cells - has a dustbin, where used substances such as proteins are discarded New hope for patients with blood cancerApril 4, 2019
The most recent advance has been our understanding that the bone marrow microenvironment supports MM cell growth, survival and development of drug resistance. Advances in Multiple MyelomaApril 4, 2019
The addition of rituximab to chemotherapy for DLBCL dramatically improved the cure rate from 40-50% to almost 70% today. When its use was introduced in indolent lymphoma, striking improvement in survival was also noted. The Role of Targeted Immunotherapies in LymphomaApril 4, 2019
I specialise in haemato-oncology (blood cancer) because... This is perhaps the most dynamic field in medicine right now Cancer ExplorerApril 4, 2019
